Announce Date | 05/08/2025 |
EPS Normalized Actual | $-0.16 (Miss by $-0.07) |
EPS GAAP Actual | $-0.16 (Miss by $-0.07) |
Revenue Actual | $1.53952B |
Revenue Surprise | Beat by $1539.52M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.04 |
EPS GAAP Estimate | $0.04 |
Revenue Estimate | $2.176043B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | -0.03273 | -67.06 | -0.03344448 | -0.03190593 | 4 |
Dec 2028 | 0.43857 | 5 | 0.42825 | 0.44595 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2012 (Sep 2012) | 0.01 | 0.01 | 1.53952B | 100% | 1539.52M |
FQ4 2012 (Dec 2012) | -0.29 | -0.29 | 1.51511B | 100% | 1515.11M |
FQ1 2025 (Mar 2025) | -0.16 | -0.138333 | 2.15228B | -4.58% | -26.82M |
FQ4 2024 (Dec 2024) | -0.12 | -0.18189 | 2.23503B | 100% | -14.37M |
FQ3 2024 (Sep 2024) | -0.0933 | -0.158245 | 2.2277B | 100% | -31.79M |
FQ2 2024 (Jun 2024) | 0.26 | -1.08259 | 2.24075B | 100% | -1814.35M |
FQ1 2024 (Mar 2024) | -0.0463 | -0.0463 | 2.25094B | 100% | 2250.94M |
FQ1 2013 (Mar 2013) | -0.03 | -0.03 | 1.51123B | 100% | 1511.23M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.04
Consensus Revenue Estimates
2.176043B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 0 | -- | 0 | 0 | 2 |
FQ3 2026 (Sep 2026) | 0 | -- | 0 | 0 | 2 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 3 |
FQ1 2026 (Mar 2026) | 0 | INF | 0 | 0 | 4 |
FQ4 2025 (Oct 2025) | 0.038 | 415.79 | 0.03758342 | 0.03833196 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Dec 2026) | 2.14B | -- | 2.14B | 2.14B | 6 |
FQ3 2026 (Sep 2026) | 2.14B | -- | 2.14B | 2.14B | 4 |
FQ2 2026 (Jun 2026) | 2.15B | -- | 2.15B | 2.15B | 4 |
FQ1 2026 (Mar 2026) | 2.15B | 0.03 | 2.15B | 2.15B | 6 |
FQ4 2025 (Oct 2025) | 2.16B | -3.56 | 2.14B | 2.17B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2012 (Sep 2012) | 0.01 | 0.01 | 100% | |
FQ4 2012 (Dec 2012) | -0.29 | -0.29 | 100% | |
FQ1 2025 (Mar 2025) | -0.021667 | -0.16 | -0.138333 | 86.46% |
FQ4 2024 (Dec 2024) | 0.06189 | -0.12 | -0.18189 | 151.58% |
FQ3 2024 (Sep 2024) | 0.064945 | -0.0933 | -0.158245 | 169.61% |
FQ2 2024 (Jun 2024) | 1.34259 | 0.26 | -1.08259 | -416.38% |
FQ1 2024 (Mar 2024) | -0.0463 | -0.0463 | 100% | |
FQ1 2013 (Mar 2013) | -0.03 | -0.03 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2012 (Sep 2012) | $0B | $1.54B | $1539.52M | 100% |
FQ4 2012 (Dec 2012) | $0B | $1.52B | $1515.11M | 100% |
FQ1 2025 (Mar 2025) | $2.18B | $2.15B | $-26.82M | -1.25% |
FQ4 2024 (Dec 2024) | $2.25B | $2.24B | $-14.37M | -0.64% |
FQ3 2024 (Sep 2024) | $2.26B | $2.23B | $-31.79M | -1.43% |
FQ2 2024 (Jun 2024) | $4.06B | $2.24B | $-1814.35M | -80.97% |
FQ1 2024 (Mar 2024) | $0B | $2.25B | $2250.94M | 100% |
FQ1 2013 (Mar 2013) | $0B | $1.51B | $1511.23M | 100% |